Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-06-14

FDA Approved: ZELAPAR — Original Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved Zelapar (selegiline hydrochloride) through the original NDA submission by Bausch Health US, LLC for its indicated use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZELAPAR (SELEGILINE HYDROCHLORIDE)

Snippet

ORIG AP for ZELAPAR (SELEGILINE HYDROCHLORIDE)